Leo Timmers

Publications

• No Benefit of Additional Treatment with Exenatide in Patients with an Acute Myocardial Infarction
  International Journal of Cardiology. Oct, 2016  |   Pubmed ID: 27394978
• Coronary Aneurysm Without Malapposition After Bioresorbable Vascular Scaffold Implantation
  EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. May, 2016  |   Pubmed ID: 27173862
• Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort
  PloS One. 2016  |   Pubmed ID: 26820481
• Suspected Acute Coronary Syndrome in the Emergency Room: Limited Added Value of Heart Type Fatty Acid Binding Protein Point of Care or ELISA Tests: The FAME-ER (Fatty Acid Binding Protein in Myocardial Infarction Evaluation in the Emergency Room) Study
  European Heart Journal. Acute Cardiovascular Care. Aug, 2016  |   Pubmed ID: 25906779
• Ethnic Differences in Clinical Outcome of Patients Presenting to the Emergency Department with Chest Pain
  European Heart Journal. Acute Cardiovascular Care. Dec, 2015  |   Pubmed ID: 26714971
• The Diagnostic and Prognostic Potential of Plasma Extracellular Vesicles for Cardiovascular Disease
  Expert Review of Molecular Diagnostics. 2015  |   Pubmed ID: 26535492
• BLT1 Antagonist LSN2792613 Reduces Infarct Size in a Mouse Model of Myocardial Ischaemia-reperfusion Injury
  Cardiovascular Research. Dec, 2015  |   Pubmed ID: 26449403
• Very Late Bioresorbable Vascular Scaffold Thrombosis Following Discontinuation of Antiplatelet Therapy
  European Heart Journal. Feb, 2015  |   Pubmed ID: 25336226
• Fast Assessment and Management of Chest Pain Without ST-elevation in the Pre-hospital Gateway: Rationale and Design
  European Heart Journal. Acute Cardiovascular Care. Apr, 2015  |   Pubmed ID: 25202026
• Leucocyte Expression of Complement C5a Receptors Exacerbates Infarct Size After Myocardial Reperfusion Injury
  Cardiovascular Research. Sep, 2014  |   Pubmed ID: 24935433
• Systemic Toll-like Receptor and Interleukin-18 Pathway Activation in Patients with Acute ST Elevation Myocardial Infarction
  Journal of Molecular and Cellular Cardiology. Feb, 2014  |   Pubmed ID: 24389343
• Serum Extracellular Vesicle Protein Levels Are Associated with Acute Coronary Syndrome
  European Heart Journal. Acute Cardiovascular Care. Mar, 2013  |   Pubmed ID: 24062934
• Optical Coherence Tomography Imaging of Acute Stent Thrombosis After Stentys Stent Implantation
  Journal of the American College of Cardiology. Apr, 2013  |   Pubmed ID: 23500257
• Microvesicle Protein Levels Are Associated with Increased Risk for Future Vascular Events and Mortality in Patients with Clinically Manifest Vascular Disease
  International Journal of Cardiology. Oct, 2013  |   Pubmed ID: 23484740
• Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
  Current Pharmaceutical Design. 2013  |   Pubmed ID: 23438953
• Mesenchymal Stem Cell-derived Exosomes Increase ATP Levels, Decrease Oxidative Stress and Activate PI3K/Akt Pathway to Enhance Myocardial Viability and Prevent Adverse Remodeling After Myocardial Ischemia/reperfusion Injury
  Stem Cell Research. May, 2013  |   Pubmed ID: 23399448
• Lack of Haptoglobin Results in Unbalanced VEGFα/angiopoietin-1 Expression, Intramural Hemorrhage and Impaired Wound Healing After Myocardial Infarction
  Journal of Molecular and Cellular Cardiology. Mar, 2013  |   Pubmed ID: 23274064
• Effect of Additional Treatment with EXenatide in Patients with an Acute Myocardial Infarction: the EXAMI Study
  International Journal of Cardiology. Jul, 2013  |   Pubmed ID: 23084550
• Treatment with OPN-305, a Humanized Anti-Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/reperfusion Injury in Pigs
  Circulation. Cardiovascular Interventions. Apr, 2012  |   Pubmed ID: 22354933
• The Innate Immune Response in Reperfused Myocardium
  Cardiovascular Research. May, 2012  |   Pubmed ID: 22266751
• Effect of Additional Treatment with EXenatide in Patients with an Acute Myocardial Infarction (EXAMI): Study Protocol for a Randomized Controlled Trial
  Trials. 2011  |   Pubmed ID: 22067476
• Human Mesenchymal Stem Cell-conditioned Medium Improves Cardiac Function Following Myocardial Infarction
  Stem Cell Research. May, 2011  |   Pubmed ID: 21419744
• Assessment of Collateral Artery Function and Growth in a Pig Model of Stepwise Coronary Occlusion
  American Journal of Physiology. Heart and Circulatory Physiology. Jan, 2011  |   Pubmed ID: 20952668
• Arteriogenesis Requires Toll-like Receptor 2 and 4 Expression in Bone-marrow Derived Cells
  Journal of Molecular and Cellular Cardiology. Jan, 2011  |   Pubmed ID: 20708624
• Exosome Secreted by MSC Reduces Myocardial Ischemia/reperfusion Injury
  Stem Cell Research. May, 2010  |   Pubmed ID: 20138817
• Myocardial Ischemia/reperfusion Injury is Mediated by Leukocytic Toll-like Receptor-2 and Reduced by Systemic Administration of a Novel Anti-toll-like Receptor-2 Antibody
  Circulation. Jan, 2010  |   Pubmed ID: 20026776
• Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
  Journal of the American College of Cardiology. Feb, 2009  |   Pubmed ID: 19195607
• Targeted Deletion of Nuclear Factor KappaB P50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction
  Circulation Research. Mar, 2009  |   Pubmed ID: 19168865
• The Nuclear Factor-kappa B P50 Subunit is Involved in Flow-induced Outward Arterial Remodeling
  Atherosclerosis. Feb, 2009  |   Pubmed ID: 18617174
• Bridging Innate Immunity and Myocardial Ischemia/reperfusion Injury: the Search for Therapeutic Targets
  Current Pharmaceutical Design. 2008  |   Pubmed ID: 18473868
• Toll-like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction
  Circulation Research. Feb, 2008  |   Pubmed ID: 18007026
• Reduction of Myocardial Infarct Size by Human Mesenchymal Stem Cell Conditioned Medium
  Stem Cell Research. Nov, 2007  |   Pubmed ID: 19383393
• Microsomal Prostaglandin E2 Synthase: a Safer Target Than Cyclooxygenases?
  Molecular Interventions. Aug, 2007  |   Pubmed ID: 17827439
• Growth Factor Therapy in Atherosclerotic Disease-friend or Foe
  Current Pharmaceutical Design. 2007  |   Pubmed ID: 17584109
• Cyclooxygenase-2 Inhibition Increases Mortality, Enhances Left Ventricular Remodeling, and Impairs Systolic Function After Myocardial Infarction in the Pig
  Circulation. Jan, 2007  |   Pubmed ID: 17210840